Robert G. Pendleton

Effects of Pharmacological Agents upon a Transgenic Model of Parkinson’s Disease in Drosophila melanogaster

Robert G. Pendleton, Feroz Parvez, M.E.S. SAYED et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 157 citations

Medicine, Neuroscience, Pharmacology +17

In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.

Victor J. Lotti, Robert G. Pendleton, R J Gould et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 139 citations

Medicine, Pharmacology, Clinical Pharmacology +10

Effects of Tyrosine Hydroxylase Mutants on Locomotor Activity in Drosophila: A Study in Functional Genomics

Robert G. Pendleton, Aseel Rasheed, Thomas Sardina et al. · Behavior Genetics · 2002 · 131 citations

Life Sciences, Genetics, Neuroscience +16

Studies on adrenal phenylethanolamine N- methyltransferase (PNMT) with S K & F 64139, a selective inhibitor.

Robert G. Pendleton, C. KAISER, George Gessner · PubMed · 1976 · 78 citations

Medicine, Endocrinology, Pharmacology +16

Studies on renal dopamine receptors with a new agonist

Robert G. Pendleton, Lucinda Samler, Carl Kaiser et al. · European Journal of Pharmacology · 1978 · 74 citations

Medicine, Endocrinology, Pharmacology +12